Statins and prostate cancer prevention: where we are now, and future directions
- 10 June 2008
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 5 (7) , 376-387
- https://doi.org/10.1038/ncpuro1146
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Secondary prevention for patients following a myocardial infarction: summary of NICE guidanceHeart, 2007
- Peroxisome Proliferator-Activated Receptors Mediate Pleiotropic Actions of StatinsCirculation Research, 2007
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007
- Pleiotropic effects of statins and related pharmacological experimental approachesMethods and Findings in Experimental and Clinical Pharmacology, 2006
- Statins and cancer preventionNature Reviews Cancer, 2005
- Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic MechanismsNature Reviews Drug Discovery, 2005
- Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular diseaseCurrent Medical Research and Opinion, 2005
- The Risk of Cancer in Users of StatinsJournal of Clinical Oncology, 2004
- Pharmacology of 3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Inhibitors (Statins), Including Rosuvastatin and PitavastatinThe Journal of Clinical Pharmacology, 2002
- Regulation of the mevalonate pathwayNature, 1990